ACP－BOP方案治疗非何杰金氏淋巴瘤110例临床评价

Clinical Evaluation of Treatmeht of Non-Hodgkin's Lympnoma with ACP-BOPScheme in 110 Case

摘要: 本文报告ACP－BOP方案治疗非何杰金氏淋巴瘤（NHL）110例的临床疗效与评价。经观察，该方案取得完全缓解率为53.6%（59/110）和有效率（CR＋PR）为95.4%（105/110）的较好疗效。毒副反应不大，病人可以耐受，是治疗NHL的较好方案之一。

Abstract: cases of NHL were treated with an alternate scheme of ACP(ADM,VCR,PRED) and BOP(Pym, VCR, PRED).Complete remission rate was 53. 6% (59/110),effectiive rate(complete remissfon tpart remission) 95. 4%(105/110).Thiseffect was satifactory. The effect of the scheme in the patients accepting first and return treatment was further analysed. The effect between the patients with and without B group symptoms and various periods and ages patients were compared in thispaper